Repros Therapeutics Inc Stock

Stocks

18-01-26	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
17-12-15	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
17-12-12	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
17-12-12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
17-12-12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

15-04-02	Apple : Les valeurs à suivre sur les marchés américains
15-04-02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	-1.78%	-1.68%	+1.99%	+13.84%	49.24B
REVOLUTION MEDICINES, INC.	+0.85%	-0.70%	+465.55%	+579.03%	43.3B
BEONE MEDICINES AG	-2.40%	-0.23%	+12.20%	+70.22%	40.48B
IQVIA HOLDINGS INC.	-2.01%	-0.85%	+24.95%	+7.51%	39.75B
CELLTRION, INC.	-0.50%	+0.85%	+20.60%	+49.65%	32.67B
MEDPACE HOLDINGS, INC.	-0.59%	-2.06%	+26.13%	+117.79%	16.24B
ASCENDIS PHARMA A/S	+0.38%	-3.23%	-	-	16.23B
EUROFINS SCIENTIFIC SE	+0.49%	+0.92%	+4.32%	+22.16%	14.04B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.43%	+4.70%	+79.75%	+29.11%	13.43B
Average	-0.60%	+0.49%	+79.44%	+111.17%	29.49B
Weighted average by Cap.	-0.93%	+0.60%	+96.21%	+132.98%

Employees

Sector